Deficient eNOS Phosphorylation Is a Mechanism for Diabetic Vascular Dysfunction Contributing to Increased Stroke Size
Author(s) -
Qian Li,
Dmitriy N. Atochin,
Satoshi Kashiwagi,
J. A. P. Earle,
Annie Wang,
Emiri T. Mandeville,
Kazuhide Hayakawa,
Livius V. d’Uscio,
Eng H. Lo,
Zvonimir S. Katušić,
William C. Sessa,
Paul L. Huang
Publication year - 2013
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.113.002073
Subject(s) - enos , medicine , endocrinology , phosphorylation , stroke (engine) , diabetes mellitus , serine , endothelial dysfunction , middle cerebral artery , cardiology , ischemia , biology , nitric oxide , nitric oxide synthase , biochemistry , mechanical engineering , engineering
Phosphorylation of eNOS, an important post-translational modulator of its enzymatic activity, is reduced in diabetes mellitus. We hypothesized that modulation of eNOS phosphorylation could overcome diabetic vascular dysfunction and improves the outcome to stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom